K150771 is an FDA 510(k) clearance for the RxG Distraction System. This device is classified as a Cranial Distraction System (Class II - Special Controls, product code PBJ).
Submitted by KLS-Martin L.P. (Jacksonville, US). The FDA issued a Cleared decision on August 27, 2015, 156 days after receiving the submission on March 24, 2015.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5330. A Cranial Distraction System Is A Metal Device Intended To Establish Osteodistraction And Bone Growth In The Skull. The Bone Segments Are Attached To The Plate With Screws To Prevent Movement Of The Segments..